poisar

Stocks · News reference

Jaguar Health Reports Third Quarter 2026 Financial Results

Fiscal.ai

Jaguar Health announced its financial results for the third quarter of 2026, highlighting a significant reduction in net loss and a strategic focus on rare disease development.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Jaguar Health, Inc. (JAGX)

    Filed: 2026-11-16 AccNo: 0001193125-26-462345 Size: 212 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits